Reckitt Benckiser Group Plc (LON:RB) insider Christopher Sinclair bought 1,076 shares of the stock in a transaction that occurred on Thursday, May 23rd. The shares were purchased at an average price of GBX 6,375 ($83.30) per share, with a total value of £68,595 ($89,631.52).

LON:RB traded up GBX 25 ($0.33) during trading hours on Thursday, reaching GBX 6,416 ($83.84). 1,887,588 shares of the company were exchanged, compared to its average volume of 1,720,000. The company has a quick ratio of 0.47, a current ratio of 0.65 and a debt-to-equity ratio of 80.49. The company has a market cap of $45.42 billion and a P/E ratio of 21.05. Reckitt Benckiser Group Plc has a 52-week low of GBX 5,559 ($72.64) and a 52-week high of GBX 7,174 ($93.74).

A number of equities research analysts have recently commented on RB shares. Barclays reaffirmed an “overweight” rating and issued a GBX 7,500 ($98.00) target price on shares of Reckitt Benckiser Group in a report on Friday, May 10th. Credit Suisse Group restated an “underperform” rating on shares of Reckitt Benckiser Group in a research report on Thursday, May 9th. Jefferies Financial Group set a GBX 5,300 ($69.25) target price on shares of Reckitt Benckiser Group and gave the stock a “sell” rating in a research report on Wednesday, May 8th. Kepler Capital Markets upgraded shares of Reckitt Benckiser Group to a “buy” rating and raised their target price for the stock from GBX 6,300 ($82.32) to GBX 6,900 ($90.16) in a research report on Tuesday, May 7th. Finally, Deutsche Bank restated a “buy” rating on shares of Reckitt Benckiser Group in a research report on Friday, May 3rd. Three investment analysts have rated the stock with a sell rating, four have given a hold rating and twelve have assigned a buy rating to the stock. Reckitt Benckiser Group currently has an average rating of “Hold” and a consensus price target of GBX 7,117.78 ($93.01).

COPYRIGHT VIOLATION NOTICE: “Reckitt Benckiser Group Plc (RB) Insider Purchases £68,595 in Stock” was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Recommended Story: Technical Indicators – What is a Golden Cross?

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with's FREE daily email newsletter.